Please login to the form below
Truberzi
This page shows the latest Truberzi news and features for those working in and with pharma, biotech and healthcare.
NICE backs Allergan's IBS therapy Truberzi
For doctors to now be able to prescribe Truberzi, a targeted treatment, this will signify real change for IBS-D sufferers," he added. ... It has also said Truberzi should only be offered in secondary care and must be discontinued after four weeks if the
Latest news
-
HIV prevention pill heads July CHMP recommendations
Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -
HIV prevention pill heads July CHMP recommendations
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital project manager
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital strategist
-
Competitive
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- GSK reveals plans for £400m R&D facility expansion in England
- EU approves bluebird bio’s CALD gene therapy Skysona
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- Using Technology-Enabled Human Interactions to Transform the Home into a Site of Care
- Langland promotes Jake Davis to managing partner
- J&J, distributors reach $26bn settlement to address the opioid crisis in the US
- Novartis sees demand returning to pre-COVID-19 levels in Q2 results
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Summer Fridays are back at Lucid Group
- Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
PMHub
Aurora Healthcare Communications
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
